General experimental procedures
NMR spectra were recorded on a Bruker AVANCE III spectrometer operating at 500 MHz for 1H NMR and 125 MHz for 13C NMR. UHPLC-MS analyses were performed on a Waters Acquity UPLC system coupled to a Waters XevoTM quadrupole time-of-flight (QToF) mas spectrometer and equipped with an electrospray source with lockspray interface for accurate mass measurements. Silica gel (70-230 mesh) was used for column chromatography, and precoated silica gel F254 (20 × 20 cm) plates for TLC, both supplied by the Merck. C18-reversed phase silica gel used for column chromatography, was purchased from Sigma.
Plant material
The roots of L. officinale were collected in July 2015 from the Hezar Mountain of Kerman Province, Iran. The plant material was identified by Prof. Farideh Attar from Tehran University. A voucher specimen (46553-TUH) has been deposited in the herbarium of the Science Faculty of Tehran University, Iran.
Extraction and isolation
Air-dried, powdered roots of L. officinale (3 kg) were extracted with n-hexane (3 x 9 L) and then ethyl acetate (3 x 9 L) by maceration at room temperature. The ethyl acetate extract was concentrated by rotary evaporation, to afford 100 g of dried extract. This extract was subjected to silica gel column chromatography (230- 400 mesh, 1 kg), with a gradient of n-hexane–EtOAc and then EtOAc–MeOH as the eluent to give 16 fractions. Fraction 6 (1.8 g) was separated on a silica gel column (230-400 mesh) into five subfractions (6a-6e). Subfraction 6a (50 mg) was applied to a reverse phase silica gel column (8 g) and eluted with methanol-water as eluent, to afford compound 1 (2 mg). Purification of subfraction 6b (40 mg) on a reverse phase silica gel (7 g) column with a gradient of methanol-water as eluent led to the isolation of compound 2 (3 mg). Subfraction 6c (70 mg) was purified on a reverse phase silica (12 g) column to give compound 3 (3.5 mg).
7-methoxy-3-propylidenephthalide (1)
Brown oil; 1H NMR (CDCl3 & CD3OD, 500 MHz) δ 7.62 (1H, t, J = 8.0 Hz, H-5), 7.21 (1H, d, J = 8.0 Hz, H-6), 6.93 (1H, d, J = 8.0 Hz, H-4), 5.63 (1H, d, J = 7.5 Hz, H-8), 4.01 (3H,s, -OCH3), 2.48 (2H, m, H-9), 1.14 (3H, t, J = 7.0 Hz, H-10), 13C NMR (125 MHz, CDCl3 & CD3OD): δ 158.7 (C-7), 147.0 (C-3), 142.3 (C-3a), 111.3 (C-4), 137.2 (C-5), 111.9 (C-6), 110.6 (C-7a(, 111.8 (C-8), 56.1 (-OCH3), 19.3 (C-9), 13.9 (C-10); HRESIMS (m/z = 205.071[M + H]+, calcd 205.086) for C12H12O3.
5-hydroxybutylidene phthalide (2)
Brown oil; 1H NMR (CDCl3 & CD3OD, 500 MHz) δ 7.76 (1H, d, J = 8.0 Hz, H-7), 7.02 (1H, s), 6.97 (1H, d, J = 8.0 Hz, H-6), 5.57 (1H, t, J = 7.8 Hz, H-8), 2.43 (2H, m, H-9), 1.54 (2H, m, H-10), 0.98 (3H, t, J = 7.0 Hz H-11), 13C NMR (125 MHz, CDCl3 & CD3OD): δ 167.4 (C-1), 161.8 (C-5), 145.1 (C-3), 141.8 (C-3a), 127.3 (C-7), 118.2 (C-6), 117.0 (C-7a), 109.6 (C-8), 105.3 (C-4), 27.7 (C-9), 22.5 (C-10), 13.8 (C-11).
7-hydroxybutylidene phthalide (3)
Brown oil; 1H NMR (CDCl3 & CD3OD, 500 MHz) δ 7.60 (1H, t, J =8.0 Hz, H-5), 7.30 (1H, d, J =8.0 Hz, H-6), 6.96 (1H, d, J =8.0 Hz, H-4), 5.84 (1H, d, J =7.7 Hz, H-8) 2.39 (2H, m, H-9), 1.65 (2H, m, H-10), 0.1.01 (3H, t, J =7.0 Hz, H-11), 13C NMR (125 MHz, CDCl3 & CD3OD): δ 158.3 (C-7), 147.7 (C-3), 142.6 (C-3a), 137.0 (C-5), 116.5 (C-6), 111.4 (C-4), 110.6 (C-7a), 109.7 (C-8), 28.0 (C-9), 22.8 (C-10), 13.7 (C-11).
Antibacterial activity
Bacterial strains
In-vitro antibacterial activity of compounds was assessed against Staphylococcus aureus ATCC 25923, Enterococcus faecium (Vancomycin-resistant clinical strain) as Gram-positive bacteria and Escherichia coli ATCC 25922 and Pseudomonas aeruginosa PTCC1430 as Gram-negative bacteria. Some strains (ATCC strains and VRE) were kindly provided by Professor M.M. Feizabadi, Tehran University of Medical sciences. PTCC strain was purchased from Iranian Research Organization for Science and Technology.
Determination of MIC
Determination of the minimum inhibitory concentration (MIC) was carried out by the broth micro-dilution method as recommended by CLSI (Clinical Laboratory and Standard Institute) with minor modifications (
10). The serial dilution of each compound was made in a range of concentrations of 256-0.015 μg/mL in sterile 96-well plates. The standard saline solution was prepared to get inoculant turbidity equal to 0.5 McFarland standards. The inoculants of the microbial strains were prepared from 20 h bacterial cultures that were adjusted to 0.5 McFarland standard turbidity and were further diluted (1:100) using MHB medium just before adding to the serially diluted samples. The plates were incubated for 24 h at 37 °C. MIC values were recorded as the lowest concentrations, which could inhibit the visible growth of the microorganisms. Each experiment was done in triplicate. Cefixime and chloramphenicol were used as the standard antibacterial agent.